Low Vitamin D status is associated with increased thyrotropin-receptor antibody titer in graves disease

Endocrine Practice

Volumn 21, Issue 3, 2015, Pages 258-263

  Zhang, Hong ^a   Liang, Lingyun ^a   Xie, Zhongjian ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALBUMIN; CALCIUM; PARATHYROID HORMONE; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROTROPIN RECEPTOR ANTIBODY; 25-HYDROXYVITAMIN D; AUTOANTIBODY; LIOTHYRONINE; THYROTROPIN RECEPTOR; THYROXINE; VITAMIN D;

ADULT; AGE; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; BODY MASS; CHEMILUMINESCENCE IMMUNOASSAY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; VITAMIN D DEFICIENCY; ANALOGS AND DERIVATIVES; BLOOD; IMMUNOLOGY; MIDDLE AGED;

ADULT; AUTOANTIBODIES; FEMALE; GRAVES DISEASE; HUMANS; MALE; MIDDLE AGED; RECEPTORS, THYROTROPIN; THYROXINE; TRIIODOTHYRONINE; VITAMIN D;

EID: 84982798821     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP14191.OR     Document Type: Article

References (30)

1. Jensen, SS, Madsen MW, Lukas J, Binderup L, Bartek J. Inhibitory effects of 1alpha, 25-dihydroxyvitamin D(3) on the G(1)-S phase-controlling machinery. Mol Endocrinol. 2001;15:1370-1380
2. Kamen, DL, Cooper GS, Bouali H, Shaftman SR, Hollis BW, Gilkeson GS. Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev. 2006;5:114-117
3. Runia TF, Hop WC, de Rijke YB, Buljevak D, Hintzen RQ. Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis. Neurology. 2012; 79:261-266
4. Varenna M, Manara M, Cantatore FP, et al. Determinants and effects of vitamin D supplementation on serum 25-Hydroxy-vitamin D levels in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2012;30:714-719
5. Greer RM, Portelli SL, Hung BS, et al. Serum vitamin D levels are lower in Australian children and adolescents with type 1 diabetes than in children without diabetes. Pediatr Diabetes. 2013;14:31-41
6. Zella JB, McCary LC and DeLuca HF. Oral administration of 1,25-dihydroxyvitamin D3 completely protects NOD mice from insulin-dependent diabetes mellitus. Arch Biochem Biophys. 2003;417:77-80
7. Lamberg-Allardt C, Valtonen E, Polojarvi M, Stewen P. Characterization of a 1,25-dihydroxy-vitamin D3 receptor in FRTL-5 cells. Evidence for an inhibitory effect of 1,25-dihydroxy-vitamin D3 on thyrotropin-induced iodide uptake. Mol Cell Endocrinol. 1991;81:25-31
8. Khadzkou K, Buchwald P, Westin G, Dralle H, Akerstrom G, Hellman P. 25-hydroxyvitamin D3 1alphahydroxylase and vitamin D receptor expression in papillary thyroid carcinoma. J Histochem Cytochem. 2006;54: 355-361
9. Sharma V, Fretwell D, Crees Z, Kerege A, Klopper JP. Thyroid cancer resistance to vitamin D receptor activation is associated with 24-hydroxylase levels but not the ff FokI polymorphism. Thyroid. 2010;20:1103-1111
10. Tamer G, Arik S, Tamer I, Coksert D. Relative vitamin D insufficiency in Hashimotos thyroiditis. Thyroid. 2011;21: 891-896
11. Bahn Chair RS, Burch HB, Cooper DS, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid. 2011;21:593-646
12. Holick MF, Binkley NC, Bischoff-Ferrari, HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911-1930
13. Binkley N, Krueger D, Cowgill CS, et al. Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization. J Clin Endocrinol Metab. 2004;89: 3152-3157
14. Antico A, Tampoia M, Tozzoli R, bizzaro N. Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature. Autoimmun Rev. 2012;12:127-136
15. Yamashita H, Noguchi S, Takatsu K, et al. High prevalence of vitamin D deficiency in Japanese female patients with Graves? disease. Endocr J. 2001;48:63-69
16. Kivity S, Agmon-Levin N, Zisappl M, et al. Vitamin D and autoimmune thyroid diseases. Cell Mol Immunol. 2011;8:243-247
17. Yasuda T, Okamoto Y, Hamada N, et al. Serum vitamin D levels are decreased and associated with thyroid volume in female patients with newly onset Graves? disease. Endocrine. 2012;42:739-741
18. Effraimidis G, Badenhoop K, Tijssen JG, Wiersinga WM. Vitamin D deficiency is not associated with early stages of thyroid autoimmunity. Eur J Endocrinol. 2012; 167:43-48
19. Goswami R, Marwaha RK, Gupta N, et al. Prevalence of vitamin D deficiency and its relationship with thyroid autoimmunity in Asian Indians: a community-based survey. Br J Nutr. 2009;102:382-386
20. Orgaz-Molina J, Buendia-Eisman A, Arrabal-Polo MA, Ruiz JC, Arias-Santiago S. Deficiency of serum concentration of 25-hydroxyvitamin D in psoriatic patients: a case-control study. J Am Acad Dermatol. 2012;67:931-938
21. Vilarrasa N, Maravall J, Estepa A, et al. Low 25-hydroxyvitamin D concentrations in obese women: their clinical significance and relationship with anthropometric and body composition variables. J Endocrinol Invest. 2007;30:653-658
22. MacFarlane IA, Mawer EB, Berry J, Hann J. Vitamin D metabolism in hyperthyroidism. Clin Endocrinol (Oxf). 1982;17:51-59
23. Jyotsna VP, Sahoo A, Ksh SA, Sreenivas V, Gupta N. Bone mineral density in patients of Graves disease pre-& post-treatment in a predominantly vitamin D deficient population. Indian J Med Res. 2012;135:36-41
24. Marazuela M, Garcia-Lpez MA, Figueroa-Vega N, et al. Regulatory T cells in human autoimmune thyroid disease. J Clin Endocrinol Metab. 2006;91:3639-3646
25. Phenekos C, Vryonidou A, Gritzapis AD, Baxevanis CN, Goula M, Papamichail M. Th1 and Th2 serum cytokine profiles characterize patients with Hashimotos thyroiditis (Th1) and Graves? disease (Th2). Neuroimmunomodulation. 2004;11:209-213
26. Cutolo M, Pizzorni C, Sulli A. Vitamin D endocrine system involvement in autoimmune rheumatic diseases. Autoimmun Rev. 2011;11:84-87
27. Misharin A, Hewison M, Chen CR, et al. Vitamin D deficiency modulates Graves? hyperthyroidism induced in BALB/ c mice by thyrotropin receptor immunization. Endocrinology. 2009;150:1051-1060
28. Yasuda T, Okamoto Y, Hamada N, et al. Serum vitamin D levels are decreased in patients without remission of Graves? disease. Endocrine. 2013;43:230-232
29. Teng CS, Yeung RT. Changes in thyroid-stimulating antibody activity in Graves? disease treated with antithyroid drug and its relationship to relapse: a prospective study. J Clin Endocrinol Metab. 1980;50:144-147
30. Carella C, Mazziotti G, Sorvillo F, et al. Serum thyrotropin receptor antibodies concentrations in patients with Graves? disease before, at the end of methimazole treatment, and after drug withdrawal: evidence that the activity of thyrotropin receptor antibody and/or thyroid response modify during the observation period. Thyroid. 2006;16:295-302